News and insights

Krone: Vienna researchers launch preventive healthcare campaign

Podcast "Börsepeople": Barbara Sladek

Where health begins: myBioma and the power of the microbiome

Mannheim: Full classes, full risk – why a healthy gut is now more important than ever

Heute: Why your gut is so important for your fitness

Microbiome: What an unhealthy gut does to your mind

Microbiome – The silent inhabitants of the gut with a huge influence

Elle: Heal your bloated stomach in 5 steps

Krone: Courageous female pioneers of tomorrow

Kurier: "A test does not make anyone healthy."

Burgopak designs packaging for myBioma’s microbiome testing kit

Gut instinct – designers benefit as gut health sector booms

trend: Away with the shackles

medianet: Women at the forefront of health policy

Antimicrobial and Metal Resistance Genes in Bacteria Isolated from Mine Water in Austria

BiomeDx ranked 24th best startup 2025 in Austria

Vienna's female pioneers: Barbara Sladek

Forward-looking Austrian innovations at EXPO 2025 in Osaka

Dynamic interplay of immune response, metabolome, and microbiota in cows during high-grain feeding: insights from multi-omics analysis

Leadersnet: myBioma launches prebiotic for improved gut health

DiePresse: About trust and digestion

Kurier: New Netflix documentary boosts demand for gut tests: What they can do

Characteristics of Gut Microbiota in Rosacea Patients-A Cross-Sectional, Controlled Pilot Study

Dietary carbohydrate sources differently prime the microbial ecosystem but not the epithelial gene expression profile along the complete gut of young calves

Universum Innere Medizin: Gut microbiome as a predictor of response to immunotherapy

Barbara Sladek featured in Forbes Austria

trend: The young health guard

Advancing microbiome research with machine learning: key findings from the ML4Microbiome COST action

BiomeDx x TrendingTopics

BiomeDx wins German Health Award 2023

Sigla storax (Liquidambar orientalis) mitigates in vitro methane production without disturbances in rumen microbiota and nutrient fermentation in comparison to monensin

Winery by-products as a feed source with functional properties: dose-response effect of grape pomace, grape seed meal, and grape seed extract on rumen microbial community and their fermentation activity in RUSITEC

Analysis of the financial impact of a predictive test to support treatment decisions in first-line patients with non-small cell lung cancer in Germany

Austrian MedTech Biome Diagnostics goes NASDAQ

BiomeDx and SanusX announce strategic partnership

Assessing the Performance of a Novel Stool-Based Microbiome Test That Predicts Response to First Line Immune Checkpoint Inhibitors in Multiple Cancer Types

Bits & Pretzels Healthtech Conference 2023

Born Global Champions Award 2023

AMICI 2023: The impact of age progression in the intestinal microbiome: insights from a European cohort

Golf Magazin: Self-test for intestinal health with myBioma

Evaluation of circulating microRNA profiles in blood as potential candidate biomarkers in a subacute ruminal acidosis cow model - a pilot study

IBS study – new collaboration

Poster: CIMT Annual Meeting 2023

CIMT 2023: Application of the microbiome-based prediction test BiomeOne quantifies antibiotic, geographical and health-related effects on response to cancer immunotherapy in a large European cohort

EIT Health Catapult Finalist

Innovationscamp St. Pölten

DACH Healthcare Innovation Summit

BIGMED-Austria Seminar

Using fecal immmunochemical cartridges for gut microbiome analysis within a colorectal cancer screening program

100 best startups 2022 in Austria

Atypical enteropathogenic E. coli are associated with disease activity in ulcerative colitis

BiomeDx among world’s best startups

BiomeDx Wins Startup Audience Award

Phönix Awards 2022

Web Summit 2022 Lisbon

Digitization of Life Sciences

The Advamed MedTech Conference 2022

BiomeDx goes Boston

UEG 2022: Analysis of colorectal cancer and adenoma microbiome signatures and the application of machine learning classification as a potential screening tool

DGHO 2022: BiomeOne®: multi-centric validation of a novel microbiome-based test to predict response to cancer immunotherapy

Poster: UEG Week 2022

Poster: DGHO Annual Meeting 2022

Poster: World Congress of Lung Cancer 2022

ÖGP 2022: Prediction of immune checkpoint inhibitor response in non-small cell lung cancer patients using a microbiome-based biomarker

Comparison of BiomeOne and PD-L1 expression tests as a predictor for response to immune checkpoint inhibitors (ICI) in patients with non-small cell lung cancer (NSCLC)

FFG Entrepreneurship Day 2022

ÖGMBT 2022: Deconfounding the intestinal microbiome signature of responders versus non- responders to immune checkpoint inhibitor therapies

Poster: 14th ÖGMBT Annual Meeting

Poster: ESMO Congress 2022

ESMO 2022: BiomeOne: Multi-centric validation of a novel microbiome-based biomarker to predict response to cancer immunotherapy

FMT Conference Copenhagen

Poster: 55th Austrian Society for Gastroenterology and Hepatology (ÖGGH) 2022

ÖGGH 2022: Analysis of colorectal cancer and adenoma microbiome signatures and the application of machine learning classification as a potential screening tool

Utility and Privacy Assessment of Synthetic Microbiome Data

Distance-based Techniques for Personal Microbiome Identification

ML4Microbiome in Turku

WCLC 2022: Introducing “BiomeOne”, a microbiome-based biomarker to predict immune checkpoint inhibitor response in NSCLC patients

Characterization of presence and activity of microRNAs in the rumen of cattle hints at possible host-microbiota cross-talk mechanism

Shift of dietary carbohydrate source from milk to various solid feeds reshapes the rumen and fecal microbiome in calves

Intestinal microbiome as cancer hope: new predictive test makes life easier for patients

Female Entrepreneur of the Year

Biome Diagnostics wins EY ScaleUp Award BioTech & Healthcare

BiomeDx at the semi-finals of the EIT Health Catapult

How to „Medizinproduktzertifizierung“?

Diversity leads to resilience

BiomeDx among 11 Start Ups to watch out in Austria!

How Big Data is driving personalised cancer therapy

Potential through personalized cancer therapy

Is data protection a hurdle or a competitive advantage?

One, two, reset: how can gut microbes change the fate of immunotherapy

TV Panel discussion: Trends in Oncology

Biome Diagnostics mentioned in Financial Times

Biome Diagnostics again under Top 100 Start-Ups in Austria!

Dr. Nikolaus Gasche is under the Top 30 under 30 at Forbes DACH

Cancer and microbiome — the long-awaited holy grail?

Biome Diagnostics identifies tumor-agnostic biomarker for cancer immunotherapy in a new meta-analysis of microbiome studies

Poster: 8th Theodor Escherich Symposium / 4th AMICI Symposium

Poster: 45th annual conference of the Austrian Society for Pneumology

ÖGP 2021: Meta-analysis on the specificity of microbiome-based signatures for predicting immune checkpoint inhibitor therapy response in non-small cell lung cancer patients

Panel discussion: European annual biotech conference Biotech Atelier 2021